Paul Shannon remembers enjoying an espresso on a spring morning in the old walled Italian city of Bergamo during one of his ...
Hosted on MSN28d
London Ranked Top City in Europe for Life SciencesMajor companies like pharma giant GlaxoSmithKline (GSK) have established their largest ... in the UK capital and includes interactive maps that make it easier to navigate London’s eight life ...
Bearish flow noted in GSK (GSK) Pharma with 5,611 puts trading, or 3x expected. Most active are Mar-25 36.5 puts and 3/14 weekly 39.5 calls, with total volume in those strikes near 6,100 contracts.
Sales growth is expected to be weighted towards the second half of the year. GSK also announced plans to buyback up to £2 billion of shares over the next 18 months. GSK expects both core ...
Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have ...
It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...
GSK (GSK) plc announced that it has completed ... The total cash consideration for this acquisition amounts to up to $1.15 billion. This includes an upfront payment of $1 billion, with the ...
One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...
US regulators have approved a new meningitis vaccine developed by GSK, sparking cautious optimism ... cause of meningitis and septicaemia. Up to one in six people who contract IMD die from the ...
GSK has revealed the data it hopes will allow a return to the US market for Blenrep, which was the first BCMA-targeting drug to launch there, but was withdrawn from sale after it failed a ...
DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results